O Shaughnessy Asset Management LLC Increases Stake in HealthEquity, Inc. (NASDAQ:HQY)

O Shaughnessy Asset Management LLC lifted its stake in HealthEquity, Inc. (NASDAQ:HQY) by 31.4% during the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 4,635 shares of the company’s stock after buying an additional 1,108 shares during the quarter. O Shaughnessy Asset Management LLC’s holdings in HealthEquity were worth $445,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently modified their holdings of the stock. Arcadia Investment Management Corp MI bought a new stake in HealthEquity in the 4th quarter valued at $26,000. Smartleaf Asset Management LLC boosted its stake in HealthEquity by 34.3% during the fourth quarter. Smartleaf Asset Management LLC now owns 384 shares of the company’s stock valued at $37,000 after buying an additional 98 shares during the last quarter. Proficio Capital Partners LLC bought a new position in HealthEquity during the fourth quarter valued at approximately $39,000. UMB Bank n.a. increased its stake in HealthEquity by 65.6% in the 4th quarter. UMB Bank n.a. now owns 414 shares of the company’s stock worth $40,000 after acquiring an additional 164 shares during the last quarter. Finally, Skandinaviska Enskilda Banken AB publ increased its stake in HealthEquity by 1,934.8% in the 4th quarter. Skandinaviska Enskilda Banken AB publ now owns 468 shares of the company’s stock worth $45,000 after acquiring an additional 445 shares during the last quarter. Institutional investors own 99.55% of the company’s stock.

HealthEquity Price Performance

HQY opened at $79.94 on Friday. The company has a quick ratio of 3.20, a current ratio of 3.20 and a debt-to-equity ratio of 0.51. The business has a fifty day moving average of $98.22 and a 200 day moving average of $96.27. HealthEquity, Inc. has a 52-week low of $65.01 and a 52-week high of $115.59. The stock has a market cap of $6.91 billion, a P/E ratio of 73.34, a PEG ratio of 1.60 and a beta of 0.49.

Analyst Upgrades and Downgrades

A number of research firms recently weighed in on HQY. Barrington Research reissued an “outperform” rating and issued a $112.00 target price on shares of HealthEquity in a report on Friday, March 14th. The Goldman Sachs Group reduced their target price on shares of HealthEquity from $107.00 to $94.00 and set a “neutral” rating on the stock in a report on Thursday, March 27th. Raymond James upgraded HealthEquity from an “outperform” rating to a “strong-buy” rating and dropped their price target for the stock from $120.00 to $115.00 in a research report on Tuesday, March 25th. KeyCorp decreased their price objective on HealthEquity from $120.00 to $110.00 and set an “overweight” rating on the stock in a research report on Monday, March 24th. Finally, Wells Fargo & Company lifted their target price on HealthEquity from $110.00 to $125.00 and gave the stock an “overweight” rating in a report on Wednesday, February 26th. One equities research analyst has rated the stock with a hold rating, ten have issued a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat, the stock presently has an average rating of “Buy” and an average price target of $112.58.

Insider Activity

In other news, EVP Michael Henry Fiore sold 8,881 shares of the firm’s stock in a transaction on Friday, April 4th. The stock was sold at an average price of $78.26, for a total transaction of $695,027.06. Following the transaction, the executive vice president now owns 56,655 shares in the company, valued at approximately $4,433,820.30. This trade represents a 13.55 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, Director Robert W. Selander sold 5,750 shares of HealthEquity stock in a transaction dated Monday, February 10th. The shares were sold at an average price of $111.29, for a total value of $639,917.50. Following the completion of the sale, the director now owns 78,219 shares of the company’s stock, valued at $8,704,992.51. The trade was a 6.85 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 2.20% of the company’s stock.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.